Dr. Chewning is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 7th Ave S
Birmingham, AL 35233Phone+1 205-939-9285
Education & Training
- New York-Presbyterian HospitalFellowship, 2001 - 2004
- University of Tennessee College of Medicine at ChattanoogaResidency, Pediatrics, 1997 - 2000
- University of South Carolina School of MedicineClass of 1997
Certifications & Licensure
- AL State Medical License 2007 - 2024
- NY State Medical License 2001 - 2008
- TN State Medical License 1997 - 2003
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML Start of enrollment: 2022 Oct 06
Roles: Contact
Publications & Presentations
PubMed
- 155 citationsKIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In VitroJoseph H. Chewning, Charlotte N. Gudme, Katharine C. Hsu, Annamalai Selvakumar, Bo Dupont
Journal of Immunology. 2007-07-15 - 23 citationsA validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.Muna Qayed, Kwang Woo Ahn, Carrie L. Kitko, Mariam H Johnson, Nirali N. Shah
Blood. 2021-02-18 - 45 citationsDevelopment and survival of Th17 cells within the intestines: the influence of microbiome- and diet-derived signalsJoseph H. Chewning, Casey T. Weaver
Journal of Immunology. 2014-11-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: